All Stories

  1. Contribution of maternal and fetal genetics to fetal weight throughout pregnancy and at birth
  2. Maternal immune gene expression trajectories and dynamic genetic regulation throughout pregnancy
  3. Isthmin-2 is a first-trimester predictor of preeclampsia and fetal growth restriction
  4. Neonatal admission as a marker of risk for poor educational attainment and special educational needs in children aged 5-11 years
  5. Raised Leptin and Pappalysin2 cell-free RNAs are the hallmarks of pregnancies complicated by preeclampsia with fetal growth restriction
  6. Genetic Variants Associated With Preeclampsia and Maternal Serum sFLT1 Levels
  7. Mendelian Randomization with longitudinal exposure data: simulation study and real data application
  8. Maternal haemoglobin levels and adverse pregnancy outcomes: individual patient data analysis from two prospective UK pregnancy cohorts
  9. Placental Streptococcus agalactiae DNA is associated with neonatal unit admission and foetal pro-inflammatory cytokines in term infants
  10. Prediction of spontaneous preterm birth using supervised machine learning on metabolomic data: A case–cohort study
  11. A multi-ancestry genome-wide association study identifies novel candidate loci in theRARBgene associated with hypertensive disorders of pregnancy
  12. Association between adverse pregnancy outcome and placental biomarkers in the first trimester: A prospective cohort study
  13. Objective measures of smoking and caffeine intake and the risk of adverse pregnancy outcomes
  14. Maternal serum levels of soluble fms-like tyrosine kinase-1 and placental growth factor at 20 and 28 weeks of gestational age and the risk of spontaneous preterm birth
  15. Association between antenatal diagnosis of late fetal growth restriction and educational outcomes in mid-childhood: A UK prospective cohort study with long-term data linkage study
  16. Increased Placental sFLT1 (Soluble fms-Like Tyrosine Kinase Receptor-1) Drives the Antiangiogenic Profile of Maternal Serum Preceding Preeclampsia but Not Fetal Growth Restriction
  17. Metabolomic Identification of a Novel, Externally Validated Predictive Test for Gestational Diabetes Mellitus
  18. Author Correction: Inherent mosaicism and extensive mutation of human placentas
  19. Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction
  20. A Maternal Serum Metabolite Ratio Predicts Large for Gestational Age Infants at Term: A Prospective Cohort Study
  21. Slowing of fetal growth and elevated maternal serum sFLT1:PlGF are associated with early term spontaneous labor
  22. The RNA landscape of the human placenta in health and disease
  23. Inherent mosaicism and extensive mutation of human placentas
  24. Comparison of estimated fetal weight percentiles near term for predicting extremes of birthweight percentile
  25. Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis
  26. Universal third-trimester ultrasonic screening using fetal macrosomia in the prediction of adverse perinatal outcome: A systematic review and meta-analysis of diagnostic test accuracy
  27. Abnormal placental CD8 + T‐cell infiltration is a feature of fetal growth restriction and pre‐eclampsia
  28. Independent influences of maternal obesity and fetal sex on maternal cardiovascular adaptation to pregnancy: a prospective cohort study
  29. Performance of a risk score for predicting preterm pre‐eclampsia
  30. Fetal inheritance of chromosomally integrated human herpesvirus 6 predisposes the mother to pre-eclampsia
  31. Performance of a risk score for predicting preterm pre-eclampsia. (Mini-commentary on BJOG-19-0970.R4)
  32. A maternal serum metabolite ratio predicts fetal growth restriction at term
  33. GWAS on longitudinal growth traits reveals different genetic factors influencing infant, child, and adult BMI
  34. Authors’ reply re: Evaluation of a simple risk score to predict preterm pre‐eclampsia using maternal characteristics: a prospective cohort study
  35. Performance of different fetal weight charts in the prediction of large‐for gestational age and associated neonatal morbidity in a multi‐ethnic, obese population
  36. 4-Hydroxyglutamate is a novel predictor of pre-eclampsia
  37. Screening for breech presentation using universal late-pregnancy ultrasonography: A prospective cohort study and cost effectiveness analysis
  38. A lower maternal cortisol to cortisone ratio precedes clinical diagnosis of preterm and term preeclampsia by many weeks
  39. Detecting eukaryotic microbiota with single-cell sensitivity in human tissue
  40. Screening performance of consensus definition of fetal growth restriction inappropriately evaluated – Authors' reply
  41. Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study
  42. Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia
  43. Blinded ultrasound fetal biometry at 36 weeks and risk of emergency Cesarean delivery in a prospective cohort study of low‐risk nulliparous women
  44. Universal vs selective ultrasonography to screen for large‐for‐gestational‐age infants and associated morbidity
  45. Reply
  46. Genome-wide oxidative bisulfite sequencing identifies sex-specific methylation differences in the human placenta
  47. The effect of customization and use of a fetal growth standard on the association between birthweight percentile and adverse perinatal outcome
  48. Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers
  49. Birth weight to placenta weight ratio and its relationship to ultrasonic measurements, maternal and neonatal morbidity: A prospective cohort study of nulliparous women
  50. A community-based motivational personalised lifestyle intervention to reduce BMI in obese adolescents: results from the Healthy Eating and Lifestyle Programme (HELP) randomised controlled trial
  51. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk
  52. Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor RatioNovelty and Significance
  53. 155: Screening for late fetal growth restriction using ultrasound and the sFlt-1:PlGF ratio
  54. Fetus-derived DLK1 is required for maternal metabolic adaptations to pregnancy and is associated with fetal growth restriction
  55. The pregnancy outcome prediction (POP) study: Investigating the relationship between serial prenatal ultrasonography, biomarkers, placental phenotype and adverse pregnancy outcomes
  56. Fetal Growth and the Risk of Spontaneous Preterm Birth in a Prospective Cohort Study of Nulliparous Women
  57. Accelerated Fetal Growth Prior to Diagnosis of Gestational Diabetes Mellitus: A Prospective Cohort Study of Nulliparous Women
  58. Screening for Fetal Growth Restriction With Universal Third Trimester Ultrasonography in Nulliparous Women in the Pregnancy Outcome Prediction (POP) Study
  59. Body mass index trajectories from 2 to 18 years – exploring differences between European cohorts
  60. Assessing within-woman changes in mammographic density: a comparison of fully versus semi-automated area-based approaches
  61. The relationship between human placental morphometry and ultrasonic measurements of utero-placental blood flow and fetal growth
  62. 556: Universal versus selective ultrasonography to detect large for gestational age (LGA) infants
  63. 103: Accelerated fetal growth precedes diagnosis of gestational diabetes mellitus (GDM)
  64. Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study
  65. Development and evaluation of an online tool for management of overweight children in primary care: a pilot study
  66. Do eating disorders in parents predict eating disorders in children? Evidence from a Swedish cohort
  67. 401: Fetal growth and the risk of spontaneous preterm birth
  68. 151: Screening for fetal growth restriction (FGR) using universal third trimester ultrasonography: a prospective cohort study of 3,977 nulliparous women
  69. Prediction of adolescent and adult adiposity outcomes from early life anthropometrics
  70. Breast Cancer Susceptibility Variants and Mammographic Density Phenotypes in Norwegian Postmenopausal Women
  71. Life course structural equation model of the effects of prenatal and postnatal growth on adult blood pressure
  72. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche
  73. Infant locomotive development and its association with adult blood pressure
  74. Stability of the Associations between Early Life Risk Indicators and Adolescent Overweight over the Evolving Obesity Epidemic
  75. Preschool Weight and Body Mass Index in Relation to Central Obesity and Metabolic Syndrome in Adulthood
  76. Comparison of fully and semi-automated area-based methods for measuring mammographic density and predicting breast cancer risk
  77. 207: First trimester placental thickness and the risk of delivering a small for gestational age infant
  78. 206: First trimester PAPP-A and the risk of fetal growth restriction
  79. LB1: Level 1 evidence for the diagnostic effectiveness of routine sonography as a screening test for small for gestational age (SGA) infants
  80. How do changes in body mass index in infancy and childhood associate with cardiometabolic profile in adulthood? Findings from the Northern Finland Birth Cohort 1966 Study
  81. Overweight in Childhood, Adolescence and Adulthood and Cardiovascular Risk in Later Life: Pooled Analysis of Three British Birth Cohorts
  82. Socioeconomic and early-life factors and risk of being overweight or obese in children of Swedish- and foreign-born parents
  83. Birth size and survival in breast cancer patients from the Uppsala Birth Cohort Study
  84. Genome-wide association and longitudinal analyses reveal genetic loci linking pubertal height growth, pubertal timing and childhood adiposity
  85. Association Study of 25 Type 2 Diabetes Related Loci with Measures of Obesity in Indian Sib Pairs
  86. Improving Prediction Algorithms for Cardiometabolic Risk in Children and Adolescents
  87. New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism
  88. Infant Growth and Adult Obesity: Relationship and Factors Affecting Them
  89. Scoping the impact of the national child measurement programme feedback on the child obesity pathway: study protocol
  90. OP41 Birth Size and Mortality in Breast Cancer Patients
  91. Social Determinants of Infant Mortality in a Historical Swedish Cohort
  92. Early and current socio-economic position and cardiometabolic risk factors in the Indian Migration Study
  93. Common variants at 6q22 and 17q21 are associated with intracranial volume
  94. Common variants at 12q15 and 12q24 are associated with infant head circumference
  95. Maternal weight gain during the first half of pregnancy and offspring obesity at 16 years: a prospective cohort study
  96. Pubertal Timing and Growth Influences Cardiometabolic Risk Factors in Adult Males and Females
  97. Assessing the efficacy of the healthy eating and lifestyle programme (HELP) compared with enhanced standard care of the obese adolescent in the community: study protocol for a randomized controlled trial
  98. Physical Activity Attenuates the Influence of FTO Variants on Obesity Risk: A Meta-Analysis of 218,166 Adults and 19,268 Children
  99. A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth order
  100. Fetal and infant growth and the risk of obesity during early childhood: the Generation R Study
  101. High-Dose Vitamin D Supplements Are Not Associated with Linear Growth in a Large Finnish Cohort1–3
  102. Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene ( AUTS2 ) in the regulation of alcohol consumption
  103. A Bivariate Genome-Wide Approach to Metabolic Syndrome
  104. Association between Common Variation at the FTO Locus and Changes in Body Mass Index from Infancy to Late Childhood: The Complex Nature of Genetic Association through Growth and Development
  105. Birthweight and mortality in adulthood: a systematic review and meta-analysis
  106. Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies
  107. Relationship between Eating Behavior, Breakfast Consumption, and Obesity Among Finnish and Greek Adolescents
  108. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution
  109. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
  110. Hundreds of variants clustered in genomic loci and biological pathways affect human height
  111. Life-Course Analysis of a Fat Mass and Obesity-Associated (FTO) Gene Variant and Body Mass Index in the Northern Finland Birth Cohort 1966 Using Structural Equation Modeling
  112. Maternal Hb during pregnancy and offspring's educational achievement: a prospective cohort study over 30 years
  113. Distinct Variants at LIN28B Influence Growth in Height from Birth to Adulthood
  114. Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight
  115. Relation of Immediate Postnatal Growth With Obesity and Related Metabolic Risk Factors in Adulthood: The Northern Finland Birth Cohort 1966 Study
  116. Genome-Wide Association Study Reveals Multiple Loci Associated with Primary Tooth Development during Infancy
  117. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
  118. Eating-Related Behaviors Measure
  119. ASSOCIATION BETWEEN FTO POLYMORPHISM, ADIPOSITY PEAK AND ADIPOSITY REBOUND IN THE NORTHERN FINLAND BIRTH COHORT 1966
  120. Early-life origins of schizotypal traits in adulthood
  121. Adolescent Manifestations of Metabolic Syndrome Among Children Born to Women With Gestational Diabetes in a General-Population Birth Cohort
  122. Genetic Determinants of Height Growth Assessed Longitudinally from Infancy to Adulthood in the Northern Finland Birth Cohort 1966
  123. Common genetic variation near MC4R is associated with eating behaviour patterns in European populations
  124. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population
  125. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population
  126. Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study
  127. A Polymorphism Within the G6PC2 Gene Is Associated with Fasting Plasma Glucose Levels
  128. Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome
  129. Size at birth, weight gain over the life course, and low-grade inflammation in young adulthood: northern Finland 1966 birth cohort study
  130. No evidence that established type 2 diabetes susceptibility variants in the PPARG and KCNJ11 genes have pleiotropic effects on early growth
  131. Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS
  132. Comparison of self-reported emotional and behavioural problems in adolescents from Greece and Finland
  133. Detailed Analysis of Variation at and around Mitochondrial Position 16189 in a Large Finnish Cohort Reveals No Significant Associations with Early Growth or Metabolic Phenotypes at Age 31 Years
  134. A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity
  135. Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels
  136. Cloninger’s Temperament Dimensions, Socio-economic and Lifestyle Factors and Metabolic Syndrome Markers at Age 31 Years in the Northern Finland Birth Cohort 1966
  137. Does vitamin D supplementation in infancy reduce the risk of pre-eclampsia?
  138. Birthweight and blood pressure in five European birth cohort studies: an investigation of confounding factors
  139. Social predictors of unsuccessful entrance into the labour market—A socialization process perspective
  140. Analysis of Multiple Data Sets Reveals No Association between the Insulin Gene Variable Number Tandem Repeat Element and Polycystic Ovary Syndrome or Related Traits
  141. No association between insulin gene variation and adult metabolic phenotypes in a large Finnish birth cohort
  142. Mothers and daughters: intergenerational patterns of reproduction
  143. Body size from birth to adulthood and bone mineral content and density at 31 years of age: results from the northern Finland 1966 birth cohort study
  144. Metabolic Cardiovascular Disease Risk Factors in Women With Self-Reported Symptoms of Oligomenorrhea and/or Hirsutism: Northern Finland Birth Cohort 1966 Study
  145. Infant Vitamin D Supplementation and Allergic Conditions in Adulthood: Northern Finland Birth Cohort 1966
  146. Early Life Factors and Blood Pressure at Age 31 Years in the 1966 Northern Finland Birth Cohort
  147. Social and Developmental Predictors of Optimism from Infancy to Early Adulthood
  148. Variation at the Insulin Gene VNTR (Variable Number Tandem Repeat) Polymorphism and Early Growth
  149. Large-Scale Analysis of the Relationship betweenCYP11APromoter Variation, Polycystic Ovarian Syndrome, and Serum Testosterone
  150. Metabolic Cardiovascular Disease Risk Factors in Women with Self-Reported Symptoms of Oligomenorrhea and/or Hirsutism: Northern Finland Birth Cohort 1966 Study
  151. Manifestations of Metabolic Syndrome After Hypertensive Pregnancy
  152. Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study
  153. Predictors of abdominal obesity among 31-y-old men and women born in Northern Finland in 1966
  154. Growth, psychomotor development and morbidity up to 3 years of age in children born after IVF
  155. Relationship between birthweight and blood lipid concentrations in later life: evidence from the existing literature
  156. Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms
  157. Hormonal Profile of Women with Self-Reported Symptoms of Oligomenorrhea and/or Hirsutism: Northern Finland Birth Cohort 1966 Study
  158. Neonatal Outcome and Congenital Malformations in Children Born After In-Vitro Fertilization
  159. Neonatal outcome and congenital malformations in children born after IVF
  160. Neonatal outcome and congenital malformations in children born after in-vitro fertilization
  161. Stress-Related Eating and Drinking Behavior and Body Mass Index and Predictors of This Behavior